Pulmonary Hypertension News13 天
MTMR7 protein shows promise as PAH treatment in mice
Boosting MTMR7 production reversed signs of pulmonary arterial hypertension in a mouse model of PAH and may serve as a ...
Pulmonary Hypertension News8 天
Corsair planning Phase 1 trial of treprostinil skin patch for PAH
Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).